SCHOTT Pharma AG & Co. KGaA (1SXP.F)

EUR 23.72

(0.08%)

Gross Profit Summary of SCHOTT Pharma AG & Co. KGaA

  • SCHOTT Pharma AG & Co. KGaA's latest annual gross profit in 2023 was 316.48 Million EUR , up 6.77% from previous year.
  • SCHOTT Pharma AG & Co. KGaA's latest quarterly gross profit in 2024 Q2 was 79.07 Million EUR , down -5.3% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported a annual gross profit of 296.42 Million EUR in annual gross profit 2022, up 31.06% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported a annual gross profit of 226.16 Million EUR in annual gross profit 2021, up 15.39% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly gross profit of 79.07 Million EUR for 2024 Q2, down -5.3% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly gross profit of 87.49 Million EUR for 2024 Q3, up 10.12% from previous quarter.

Annual Gross Profit Chart of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Historical Annual Gross Profit of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 316.48 Million EUR 6.77%
2022 296.42 Million EUR 31.06%
2021 226.16 Million EUR 15.39%
2020 196 Million EUR 0.0%

Peer Gross Profit Comparison of SCHOTT Pharma AG & Co. KGaA

Name Gross Profit Gross Profit Difference
Carl Zeiss Meditec AG 1.2 Billion EUR 73.752%
Fielmann Aktiengesellschaft 576.41 Million EUR 45.093%
Gerresheimer AG 597.31 Million EUR 47.015%
Sartorius Aktiengesellschaft 1.56 Billion EUR 79.804%
Sartorius Aktiengesellschaft 1.56 Billion EUR 79.804%